Dr Ana M Saavedra-delgado, MD | |
9633 Culver St, Kensington, MD 20895-3631 | |
(703) 573-4440 | |
(703) 280-4650 |
Full Name | Dr Ana M Saavedra-delgado |
---|---|
Gender | Female |
Speciality | Allergy & Immunology - Allergy |
Location | 9633 Culver St, Kensington, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346240058 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 0101054294 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ana M Saavedra-delgado, MD 9633 Culver St, Kensington, MD 20895-3631 Ph: (301) 942-1343 | Dr Ana M Saavedra-delgado, MD 9633 Culver St, Kensington, MD 20895-3631 Ph: (703) 573-4440 |
News Archive
An analysis linking federal bankruptcy court records to cancer registry data from nearly 232,000 adult cancer cases in western Washington during a 14-year period has found a hidden cost to survival: Insolvency rates increase along with the length of survival.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of three blockbuster antibiotics - levofloxacin, moxifloxacin and piperacillin/tazobactam - will be the primary factors contributing to a decline of more than 15 percent in the community-acquired pneumonia drug market though 2018.
Scientists from the Center for Radiological Research at Columbia University Medical Center have shown that a narrow wavelength of ultraviolet (UV) light safely killed drug-resistant MRSA bacteria in mice, demonstrating a potentially safe and cost-effective way to reduce surgical site infections, a major public health concern.
Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
One of the most debated parts of the health care law is the requirement that most Americans buy insurance starting this year. … But it's not clear that the IRS will deploy much in the way of resources to aggressively search for individuals who don't get coverage this first year (Adams, 2/24).
› Verified 8 days ago
Dr. Betty W Chang, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7461 |